From 2002 to 2020, there were over 1,000 mergers of US hospitals. During this period, the Federal Trade Commission (FTC) took enforcement actions against 13 transactions. However, using the FTC’s standard screening tools, we find that 20% of these mergers could have been predicted to meaningfully lessen competition. We then show that, from 2010 to 2015, predictably anticompetitive mergers resulted in price increases over 5%. We estimate that approximately half of predictably anticompetitive mergers had to be reported to the FTC per the Hart-Scott-Rodino Act. We conclude that there appears to be underenforcement of antitrust laws in the hospital sector.

More on this topic

BFI Working Paper·May 13, 2025

Saved by Medicaid: New Evidence on Health Insurance and Mortality from the Universe of Low-Income Adults

Angela Wyse and Bruce Meyer
Topics: Health care, Tax & Budget
BFI Working Paper·Apr 28, 2025

Screening Through Soft Spending Limits: Evidence from the Medicare Therapy Cap

Ashvin Gandhi and Maggie Shi
Topics: Health care
BFI Working Paper·Apr 23, 2025

Evaluating Recent Crackdowns on Disability Benefits: Effects on Income and Health Care Use in Australia

Manasi Deshpande, Greg Kaplan, and Tobias Leigh-Wood
Topics: Employment & Wages, Health care